Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Entertainment

Paramount Vs. Comcast: Sheridan Walks — What Happens To ‘Yellowstone’ Now?

By Chris Katje
Today, 2:54 PM
The creator of the hit "Yellowstone" franchise is taking his talents from Paramount to Comcast. Here's what happens to his shows.

CMCSA

Read More
1 minute read
  • News

Alpha Modus Holdings Entered Into Consulting Agreements With Rucus Holdings And Leron Group; To Issue Rucus 250,000 Shares Of Class A Common Stock & Issue Leron 4M Shares Of Class A Common Stock

By Benzinga Newsdesk
Today, 2:54 PM
-SEC Filing

AMOD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Guggenheim Reiterates Buy on Summit Therapeutics, Maintains $40 Price Target

By Benzinga Newsdesk
Today, 2:54 PM
Guggenheim analyst Brad Canino reiterates Summit Therapeutics (NASDAQ:SMMT) with a Buy and maintains $40 price target.

SMMT

Read More
1 minute read
  • Analyst Ratings
  • Hot
  • News
  • Price Target

Scotiabank Maintains Sector Outperform on Oracle, Raises Price Target to $360

By Benzinga Newsdesk
Today, 2:54 PM
Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.

ORCL

Read More
2 minute read
  • SPACE
  • Tech

Jeff Bezos Sees Millions Living In Space In Coming Decades, Elon Musk Says Mars Colony Needs 100K People

By Badar Shaikh
Today, 2:54 PM
Jeff Bezos believes humans could live in space within decades. He also supports using robots for space work.

AMZN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

JP Morgan Maintains Neutral on Herc Holdings, Raises Price Target to $140

By Benzinga Newsdesk
Today, 2:54 PM
JP Morgan analyst Tami Zakaria maintains Herc Holdings (NYSE:HRI) with a Neutral and raises the price target from $127 to $140.

HRI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

CIBC Maintains Neutral on Royal Gold, Raises Price Target to $250

By Benzinga Newsdesk
Today, 2:54 PM
CIBC analyst Anita Soni maintains Royal Gold (NASDAQ:RGLD) with a Neutral and raises the price target from $225 to $250.

RGLD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Equal-Weight on Lincoln National, Raises Price Target to $46

By Benzinga Newsdesk
Today, 2:54 PM
Barclays analyst Alex Scott maintains Lincoln National (NYSE:LNC) with a Equal-Weight and raises the price target from $42 to $46.

LNC

Read More
11 minute read
  • Commodities
  • Opinion
  • Trading Ideas

Gold and Silver Miners Set To Outperform As Capital Rotates Away From US Equities

By Abolade Akinfenwa
Today, 2:54 PM
Every market transition begins in silence. Before the headlines catch on, before analysts start revising their models, and…
Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Needham Initiates Coverage On Red Cat Holdings with Buy Rating, Announces Price Target of $17

By Benzinga Newsdesk
Today, 2:54 PM
Needham analyst Austin Bohlig initiates coverage on Red Cat Holdings (NASDAQ:RCAT) with a Buy rating and announces Price Target of $17.

RCAT

Posts navigation

1 2 … 20,904 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service